J&J in Vaccine Deal with U.S.; Deaths Top 700,000: Virus Update

Johnson & Johnson will supply 100 million doses of its experimental Covid-19 vaccine to the U.S. The U.K. agreed to invest $18 million in a Scottish vaccine-manufacturing plant, while Moderna Inc. said it has received $400 million of deposits for its potential Covid-19 shot.